🔗 Visit the ClinicalTrials.gov page for NCT01049841
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Akt inhibitors in clinical development for the treatment of cancer. | Expert Opin Investig Drugs | 2010 | 2.01 |
| 2 | Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. | Eur J Cancer | 2011 | 1.15 |
| 3 | New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. | Clin Cancer Res | 2013 | 1.02 |
| 4 | Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine. | Onco Targets Ther | 2012 | 0.80 |
| 5 | Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration. | Front Oncol | 2013 | 0.79 |
| 6 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |
| 7 | Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors. | Clin Med Insights Oncol | 2010 | 0.75 |